Document:

EX-10.4

 Exhibit 10.4 

INCENTIVE STOCK OPTION AGREEMENT 

PURSUANT TO THE 

ALTIMMUNE, INC. 2017 OMNIBUS INCENTIVE PLAN 

* * * * * 
 Participant: Elizabeth
Czerepak 
 Grant Date: September 22, 2017 
 Per Share
Exercise Price: $2.48 
 Number of Shares of Common Stock subject to this Option: 62,500 

Vesting: 
 A. Provided that the Participant has
not incurred a Termination prior to March 31, 2019 (the “Time Based Condition”), this Option shall vest and become exercisable (i.e., no longer be subject to forfeiture) on March 31, 2019 in three tranches as
follows (the “Performance Based Condition”): 
 (a) One-third
(1/3rd) of this Option shall vest and become exercisable if, and only if, at any time during the period commencing on the Grant Date and ending on December 31, 2018 (the
“Performance Period”), the Company’s Common Stock attained a closing price on the NASDAQ stock exchange equal to or greater than $3.75 per share for at least ten (10) consecutive trading days; 

(b) An additional one-third (1/3rd) of this Option shall vest and become exercisable
if, and only if, at any time during the Performance Period, the Company’s Common Stock attained a closing price on the NASDAQ stock exchange equal to or greater than $5.00 per share for at least ten (10) consecutive trading days; and 

(c) The remaining one-third (1/3rd) of this Option shall vest and become exercisable
if, and only if, at any time during the Performance Period, the Company’s Common Stock attained a closing price on the NASDAQ stock exchange equal to or greater than $6.50 per share for at least ten (10) consecutive trading days. 

B. Notwithstanding the foregoing: 

(a) if a Change in Control shall occur on or before December 31, 2018, and the employment of the Participant is terminated by the Company
(or any successor thereto) without Cause (as defined below) or by the Participant for Good Reason (as defined below) within the period commencing on the occurrence of such Change in Control and ending on the earlier of (x) the first anniversary
of such Change in Control and (y) March 30, 2019, then (i) the Time Based Condition shall be deemed to have been satisfied; and (ii) the achievement of the applicable stock price for each of the three tranches of the Performance
Based Condition shall be determined with reference to the fair market value (as determined by the Committee in its sole discretion) of the consideration per share of Common Stock paid or payable to the stockholders of the Company in respect of the
consummation of such Change in Control on the date of the consummation of such Change in Control (and not, for the avoidance of doubt, any consideration that may subsequently become payable, whether pursuant to any earnouts, royalties, milestone
payments, escrows, holdbacks or otherwise); and 
 (b) if a Change of Control shall occur after December 31, 2018 and on or before
March 31, 2019, and the employment of the Participant is terminated by the Company (or any successor thereto) without Cause or by the Participant for Good Reason prior to March 31, 2019, then (i) the Time Based Condition shall be
deemed to have been satisfied; and (ii) the achievement of the applicable stock price for each of the three tranches of the Performance Based Condition shall be determined pursuant to Section A above during the Performance Period ending on
December 31, 2018. 

 C. The terms “Cause,” “Good Reason,” and “Change in Control” shall
have the meanings given to them in the Participant’s Employment Agreement with the Company, dated December 7, 2015, as amended effective January 18, 2017 (the “Employment Agreement”) 

D. Notwithstanding anything contained in the Employment Agreement to the contrary, this Option shall not vest other than as expressly set
forth above; provided that the Committee may, at any time, in its sole discretion, accelerate the vesting of all or any portion of this Option. 

* * * * * 
 THIS INCENTIVE
STOCK OPTION AWARD AGREEMENT (this “Agreement”), dated as of the Grant Date specified above, is entered into by and between Altimmune, Inc., a Delaware corporation (the “Company”), and the Participant specified
above, pursuant to the Altimmune, Inc. 2017 Omnibus Incentive Plan, as in effect and as amended from time to time (the “Plan”), which is administered by the Committee; and 

WHEREAS, it has been determined under the Plan that it would be in the best interests of the Company to grant the incentive stock option
provided for herein to the Participant. 
 NOW, THEREFORE, in consideration of the mutual covenants and promises hereinafter set forth and
for other good and valuable consideration, the parties hereto hereby mutually covenant and agree as follows: 
 1. Incorporation By
Reference; Plan Document Receipt. This Agreement is subject in all respects to the terms and provisions of the Plan (including, without limitation, any amendments thereto adopted at any time and from time to time unless such amendments are
expressly intended not to apply to the award provided hereunder), all of which terms and provisions are made a part of and incorporated in this Agreement as if they were each expressly set forth herein. Any capitalized term not defined in this
Agreement shall have the same meaning as is ascribed thereto in the Plan. The Participant hereby acknowledges receipt of a true copy of the Plan and that the Participant has read the Plan carefully and fully understands its content. In the event of
any conflict between the terms of this Agreement and the terms of the Plan, the terms of the Plan shall control. 
 2. Grant of
Option. The Company hereby grants to the Participant, as of the Grant Date specified above, an incentive stock option (this “Option”) to acquire from the Company at the Per Share Exercise Price specified above, the aggregate
number of shares of Common Stock specified above (the “Option Shares”). Except as otherwise provided by the Plan, the Participant agrees and understands that nothing contained in this Agreement provides, or is intended to provide,
the Participant with any protection against potential future dilution of the Participant’s interest in the Company for any reason. The Participant shall have no rights as a stockholder with respect to any shares of Common Stock covered by this
Option unless and until the Participant has become the holder of record of the shares of Common Stock, and no adjustments shall be made for dividends in cash or other property, distributions or other rights in respect of any such shares, except as
otherwise specifically provided for in the Plan or this Agreement. 
 3. Tax Matters. The Option granted hereby is intended to
qualify as an “incentive stock option” under Section 422 of the Code. Notwithstanding the foregoing, the Option will not qualify as an “incentive stock option,” among other events, (a) if the Participant disposes of the
Option Shares at any time during the two-year period following the date of this Agreement or the one-year period following the date of any exercise of the Option; (b) except in the event of the Participant’s death or Disability, if the

  
 2 

 
Participant is not employed by the Company, a Parent or a Subsidiary at all times during the period beginning on the date of this Agreement and ending on the day that is three months before the
date of any exercise of the Option; or (c) to the extent the aggregate fair market value of the Common Stock subject to “incentive stock options” held by the Participant which become exercisable for the first time in any calendar year
(under all plans of the Company, a Parent or a Subsidiary) exceeds $100,000. For purposes of clause (c) above, the “fair market value” of the Common Stock shall be determined as of the Grant Date. To the extent that the Option does
not qualify as an “incentive stock option,” it shall not affect the validity of the Option and shall constitute a separate non-qualified stock option. In the event that the Participant disposes of the Option Shares within either two
(2) years following the Grant Date or one year following the date of exercise of the Option, the Participant must deliver to the Company, within seven (7) days following such disposition, a written notice specifying the date on which such
shares were disposed of, the number of shares of Common Stock so disposed, and, if such disposition was by a sale or exchange, the amount of consideration received. 

4. Vesting; Detrimental Activity; Expiration. 

(a) Vesting. The Option subject to this grant shall become vested in accordance with the vesting schedule specified above. All vesting
of the Option granted hereunder shall occur only on the appropriate vesting date specified above, subject to the Participant’s continued service with the Company or any of its Subsidiaries through each applicable vesting date. There shall be no
proportionate or partial vesting in the periods prior to each vesting date. 
 (b) Effect of Detrimental Activity. The provisions of
Section 6.3(c)(ii) of the Plan regarding Detrimental Activity shall apply to the Option. The Participant acknowledges and agrees that the restrictions herein and in the Plan regarding Detrimental Activity are necessary for the protection of the
business and goodwill of the Company and its Affiliates, and are considered by the Participant to be reasonable for such purposes. Without intending to limit the legal or equitable remedies available in the Plan and in this Agreement, the
Participant acknowledges that engaging in Detrimental Activity will cause the Company and its Affiliates material irreparable injury for which there is no adequate remedy at law, that it will not be possible to measure damages for such injuries
precisely and that, in the event of such activity or threat thereof, the Company shall be entitled, in addition to the remedies provided under the Plan, to obtain from any court of competent jurisdiction a temporary restraining order or a
preliminary or permanent injunction restraining the Participant from engaging in Detrimental Activity or such other relief as may be required to specifically enforce any of the covenants in the Plan and this Agreement without the necessity of
posting a bond, and in the case of a temporary restraining order or a preliminary injunction, without having to prove special damages. 

(c) Expiration. The term of the Option shall be until the tenth anniversary of the Grant Date, after which time it shall expire (such
tenth anniversary date, the “Expiration Date”), subject to earlier termination in the event of the Participant’s Termination as specified in the Plan and this Agreement. Upon the Expiration Date, the Option (whether vested or
not) shall automatically be cancelled for no consideration, shall no longer be exercisable, and shall cease to be outstanding. 
 5.
Termination. Subject to the terms of the Plan and this Agreement, the Option, to the extent vested at the time of the Participant’s Termination, shall remain exercisable as follows: 

(a) Termination due to Death or Disability. In the event of the Participant’s Termination by reason of death or Disability, the
vested portion of this Option shall remain exercisable until the earlier of (i) one year from the date of such Termination, and (ii) the Expiration Date. 

(b) Termination Without Cause. In the event of the Participant’s involuntary Termination by the Company without Cause, the vested
portion of this Option shall remain exercisable until the earlier of (i) ninety (90) days from the date of such Termination, and (ii) the Expiration Date. 

  
 3 

 (c) Voluntary Termination. In the event of the Participant’s voluntary Termination,
the vested portion of this Option shall remain exercisable until the earlier of (i) thirty (30) days from the date of such Termination, and (ii) the Expiration Date. 

(d) Termination for Cause. In the event of the Participant’s Termination by the Company for Cause (or in the event of a
voluntary Termination by the Participant after the occurrence of an event that would be grounds for a Termination for Cause), the Option granted hereunder (whether or not vested) shall terminate and expire upon such Termination. 

(e) Treatment of Unvested Option upon Termination. Any portion of this Option that is not vested as of the date of the
Participant’s Termination for any reason shall terminate and expire as of the date of such Termination. 
 6. Method of Exercise
and Payment. Subject to Section 9 hereof, to the extent that the Option has become vested and exercisable with respect to a number of shares of Common Stock as provided herein, the Option may thereafter be exercised by the Participant,
in whole or in part, at any time or from time to time prior to the expiration of the Option as provided herein and in accordance with Section 6.3 of the Plan, including, without limitation, by the delivery of any form of exercise notice as may
be required by the Committee and payment in full of the Per Share Exercise Price multiplied by the number of shares of Common Stock underlying the portion of the Option exercised. 

7. Non-transferability. The Option, and any rights and interests with respect thereto, issued under this Agreement and the
Plan shall not, prior to vesting, be sold, exchanged, Transferred, assigned or otherwise disposed of in any way by the Participant (or any beneficiary(ies) of the Participant), other than by testamentary disposition by the Participant or the laws of
descent and distribution. Any attempt to sell, exchange, Transfer, assign, pledge, encumber or otherwise dispose of or hypothecate in any way the Option, or the levy of any execution, attachment or similar legal process upon the Option, contrary to
the terms and provisions of this Agreement and/or the Plan shall be null and void and without legal force or effect. 
 8. Governing
Law. All questions concerning the construction, validity and interpretation of this Agreement shall be governed by, and construed in accordance with, the laws of the State of Delaware, without regard to choice of law principles (whether of
the State of Delaware or otherwise) that would result in the application of the law of any other jurisdiction. 
 9. Withholding of
Tax. The Company or any Affiliate shall have the power and the right to deduct or withhold, require the Participant to remit to the Company or such Affiliate, or make any other arrangements as it considers appropriate to ensure that it
has received, an amount sufficient to satisfy any federal, state, local and foreign taxes of any kind (including, but not limited to, the Participant’s FICA and SDI obligations) which the Company, in its sole discretion, deems necessary to be
withheld or remitted to comply with the Code and/or any other applicable law, rule or regulation with respect to the Option and, if the Participant fails to do so, the Company may otherwise refuse to issue or Transfer any shares of Common Stock
otherwise required to be issued pursuant to this Agreement. 
 10. Recoupment Policy. The Participant acknowledges and agrees
that this Option (including any shares of Common Stock issued upon exercise thereof) shall be subject to the terms and provisions of any “clawback” or recoupment policy that may be adopted by the Company or its Affiliates from time to time
or as may be required by any applicable law (including, without limitation, the Dodd-Frank Wall Street Reform and Consumer Protection Act and implementing rules and regulations thereunder). 

11. Notices. Any notice or communication given hereunder shall be in writing and shall be deemed to have been duly given:
(i) when delivered in person; (ii) two (2) days after being sent by United 

  
 4 

 
States mail; or (iii) on the first business day following the date of deposit if delivered by a nationally recognized overnight delivery service, in each case, to the appropriate party at
the address set forth below (or such other address as the party may from time to time specify): 
 If to the Company, to:

 Altimmune, Inc. 

19 Firstfield Road, Suite 200 

Gaithersburg, MD 20878 

Attention: Chief Executive Officer 

with a copy (which shall not constitute notice) to: 

Proskauer Rose LLP 

One International Place 

Boston, MA 02110 

Attention: Ori Solomon, Esq. 

If to the Participant, to the address on file with the Company. 

12. No Right to Employment. Nothing contained in this Agreement shall affect the right of the Company or any of its Affiliates
to terminate the Participant’s employment at any time, with or without Cause, or shall be deemed to create any rights to employment or continued employment. The rights and obligations arising under this Agreement are not intended to and do not
affect the Participant’s employment relationship that otherwise exists between the Participant and the Company or any of its Affiliates, whether such employment relationship is at will or defined by an employment contract. Moreover, this
Agreement is not intended to and does not amend any existing employment contract between the Participant and the Company or any of its Affiliates; to the extent there is a conflict between this Agreement and such an employment contract, the
employment contract shall govern and take priority. 
 13. Data Protection. By executing this Agreement, the Participant
hereby consents to the holding and processing of personal information provided by the Participant to the Company, any Affiliate thereof, trustee or third party service provider, for all purposes relating to the operation of the Plan. These include,
but are not limited to: (i) administering and maintaining Participant records; (ii) providing information to the Company, its Affiliates, trustees of any employee benefit trust, registrars, brokers or third party administrators of the
Plan; (iii) providing information to future purchasers or merger partners of the Company or any Affiliate thereof, or the business in which the Participant works; and (iv) transferring information about the Participant to any country or
territory that may not provide the same protection for the information as the Participant’s home country. 
 14. Market
Stand-Off. If requested by the Company, any Affiliate or the lead underwriter of any public offering of the shares of Common Stock (the “Lead Underwriter”), the Participant shall irrevocably agree not to sell, contract to
sell, grant any option to purchase, transfer the economic risk of ownership in, make any short sale of, pledge or otherwise Transfer or dispose of, any interest in any shares of Common Stock or any securities convertible into, derivative of, or
exchangeable or exercisable for shares of Common Stock, or any other rights to purchase or acquire shares of Common Stock (except shares of Common Stock included in such public offering or acquired on the public market after such offering) during
such period of time following the effective date of a registration statement of the Company filed under the Securities Act that the Lead Underwriter shall specify (the “Lock-up Period”). The Participant shall further agree to sign
such documents as may be requested by the Lead Underwriter, the Company or any Affiliate to effect the foregoing and agree that the Company or an Affiliate may 

  
 5 

 
impose stop transfer instructions with respect to shares of Common Stock acquired pursuant to an Award until the end of such Lock-up Period. 

15. Compliance with Laws. The issuance of this Option (and the shares of Common Stock upon exercise of this Option) pursuant to
this Agreement shall be subject to, and shall comply with, any applicable requirements of any foreign and U.S. federal and state securities laws, rules and regulations (including, without limitation, the provisions of the Securities Act, the
Exchange Act and in each case any respective rules and regulations promulgated thereunder) and any other law or regulation applicable thereto. The Company shall not be obligated to issue this Option or any of the shares of Common Stock pursuant to
this Agreement if any such issuance would violate any such requirements. 
 16. Section 409A. Notwithstanding anything
herein or in the Plan to the contrary, the Option is intended to be exempt from the applicable requirements of Section 409A of the Code and shall be limited, construed and interpreted in accordance with such intent. 

17. Binding Agreement; Assignment. This Agreement shall inure to the benefit of, be binding upon, and be enforceable by the
Company and its successors and assigns. The Participant shall not assign any part of this Agreement without the prior express written consent of the Company. 

18. Headings. The titles and headings of the various sections of this Agreement have been inserted for convenience of reference
only and shall not be deemed to be a part of this Agreement. 
 19. Counterparts. This Agreement may be executed in one
or more counterparts, each of which shall be deemed to be an original, but all of which shall constitute one and the same instrument. 
 20.
Severability. The invalidity or unenforceability of any provisions of this Agreement in any jurisdiction shall not affect the validity, legality or enforceability of the remainder of this Agreement in such jurisdiction or the validity,
legality or enforceability of any provision of this Agreement in any other jurisdiction, it being intended that all rights and obligations of the parties hereunder shall be enforceable to the fullest extent permitted by law. 

21. Entire Agreement; Amendment. This Agreement, together with the Plan, contains the entire agreement between the parties
hereto with respect to the subject matter contained herein, and supersedes all prior agreements or prior understandings, whether written or oral, between the parties relating to such subject matter. The Committee shall have the right, in its sole
discretion, to modify or amend this Agreement from time to time in accordance with and as provided in the Plan. This Agreement may also be modified or amended by a writing signed by both the Company and the Participant. The Company shall give
written notice to the Participant of any such modification or amendment of this Agreement as soon as practicable after the adoption thereof. 

22. Mode of Communications. The Participant agrees, to the fullest extent permitted by applicable law, in lieu of receiving
documents in paper format, to accept electronic delivery of any documents that the Company or any of its Affiliates may deliver in connection with this Option grant and any other grants offered by the Company or its Affiliates, including, without
limitation, prospectuses, grant notifications, account statements, annual or quarterly reports, and other communications. Electronic delivery of a document may be made via the Company’s email system or by reference to a location on the
Company’s intranet or website or the online brokerage account system. 
 23. Acquired Rights. The Participant
acknowledges and agrees that: (a) the Company may terminate or amend the Plan at any time; (b) the award of the Option made under this Agreement is completely independent of any other award or grant and is made at the sole discretion of
the Company; (c) no past grants or awards (including, without limitation, the Option awarded hereunder) give the Participant any right to any grants or awards in the future whatsoever; and (d) any benefits granted under

  
 6 

 
this Agreement are not part of the Participant’s ordinary salary, and shall not be considered as part of such salary in the event of severance, redundancy or resignation. 

[Remainder of Page Intentionally Left Blank] 

  
 7 

 IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first
written above. 
  

			
	ALTIMMUNE, INC.

 
			
		
	By:	 	 
	Name:	 	 
	Title:	 	 

 
			
	
	PARTICIPANT
	
	   

 
			
	 Name:
	 	Elizabeth Czerepak

 
	
	
Social Security Number:             
                                        
               

  
 8EX-10.1

 Exhibit 10.1 

November 6, 2017 
 Dear Ron: 

I am very pleased to outline in this letter (the “Offer Letter”) the terms and conditions on which we are offering you employment with S.
& D. Coffee, Inc. (the “Company”), a subsidiary of Cott Corporation (“Cott”), in the position of Chief Executive Officer of the Company. This Offer Letter will not constitute an agreement unless and until it has
been fully executed by both parties. Please note that this Offer Letter does not contemplate a contract or promise of employment for any specific term; you will be an at-will employee at all times. To the
extent not defined herein, capitalized terms shall have the meanings provided in Exhibit A hereto. 
 1. Position and Duties. 

1.1 Position. Subject to the terms and conditions hereof, you will be employed by the Company as the Chief
Executive Officer, effective as of the date hereof (the “Employment Date”). 
 1.2 Responsibilities. 

(a) As the Company’s Chief Executive Officer, you will report to the Chief Executive Officer of Cott Corporation and have such duties and
responsibilities as may be assigned to you from time to time by the Chief Executive Officer. 
 (b) You agree to devote all of your business
time and attention to the business and affairs of the Company and, upon request, Cott and its Affiliates, and to discharge the responsibilities assigned to you. This shall not preclude you from (i) serving on the boards of directors of a
reasonable number of charitable organizations, (ii) engaging in charitable activities and community affairs, and (iii) managing your personal affairs, so long as these activities do not interfere with the performance of your duties and
responsibilities. 
 1.3 No Employment Restriction. You hereby represent and covenant that your employment by
the Company does not violate any agreement or covenant to which you are subject or by which you are bound and that there is no such agreement or covenant that could restrict or impair your ability to perform your duties or discharge your
responsibilities to the Company. 
 1.4 Term. The Company agrees to employ you pursuant to the terms of this Offer
Letter, and you agree to be so employed, commencing as of the Employment Date and continuing until such time as your employment is terminated in accordance with Sections 4 and 5 hereof. The period of time between the Employment Date and the
termination of your employment hereunder shall be referred to herein as the “Employment Term.” 
 2. Remuneration. 

2.1 Base Salary. Your annual base salary will initially be at the rate of $1,000,000 per year (“Annual
Base Salary”), paid on a bi-weekly basis (or such other basis as the Company may later adopt), prorated for any partial periods based on the actual number of days in the applicable period. 

 

 2.2 Annual Bonus. You will be eligible to participate in the
Company’s annual bonus plan and may earn a bonus based upon the achievement of specified performance goals. The amount of your target bonus is one hundred percent (100 %) of your Annual Base Salary. The bonus year is the Company’s fiscal
year. Please note that the bonus plan is entirely discretionary, and the Company reserves in its absolute discretion the right to terminate or amend it or any other bonus plan that may be established. 

3. Benefits.
 3.1
Benefit Program. You will continue to be eligible to participate in the Company’s benefit programs generally available to other senior executives of the Company. The Company’s benefit programs include health,
disability and life insurance benefits. Employee contributions are required for the Company’s benefit programs. 
 3.2
401(k) Plan. In addition, you will continue to be eligible to continue to participate in the Company’s 401(k) Savings and Retirement Plan. 

3.3 Vacation; Personal Time. You will be entitled to five (5) weeks’ vacation and one (1) week of personal
time per calendar year. All earned vacation and personal time must be taken in the year in which it is earned; otherwise it shall be forfeited. If you should leave the Company, the value of any unearned vacation and personal time taken by you prior
to your separation will be considered a debt to the Company. All vacation and personal time periods require the approval of Mr. Fowden. 

3.4 Reimbursement. You will be reimbursed for expenses reasonably incurred in connection with the performance of
your duties in accordance with the Company’s policies as established from time to time. 
 3.5 No Other
Benefits. You will not be entitled to any benefit or perquisite other than as specifically set out in this Offer Letter or separately agreed to in writing by the Company. 

4. Separation; Payments and Entitlements Upon a Separation. 

4.1 Termination. The Company may terminate your employment: (a) immediately for Cause, (b) upon your
Disability, or (c) upon thirty (30) days’ notice for any other reason or no reason. Your employment with the Company will terminate upon your death. 

4.2 Termination By the Company Without Cause or By You with Good Reason. Subject to Sections 4.3, 7.9, and 9.11,
if your employment is terminated following the Employment Date (i) by the Company without Cause other than by reason of your Disability or (ii) by you for Good Reason, you will be entitled to the following payments and entitlements: 

(a) Cash Payment. You will receive a cash payment in an amount equal to the sum of (1) twelve (12) months of your then Annual Base
Salary, and (2) the average of the bonus received by you in the two most recently completed calendar years or, if you have not been in the employ of the Company for the two most recent completed calendar years, your target bonus amount (the
“Cash Payment Amount”). The Cash Payment Amount will be paid in a lump sum, less all applicable withholding taxes, within thirty (30) days after your separation date, except in the case

  
 -2- 

 
of an involuntary termination that is part of a group termination program, in which case the payment shall be made within sixty (60) days after your separation date. The Cash Payment Amount
will not be considered as compensation for purposes of determining benefits under any other qualified or non-qualified plans of the Company. 

(b) Accrued Salary and Vacation. You will be paid all salary and accrued, unused vacation pay earned through the date of your
separation pursuant to this Section 4.2, less all applicable withholding taxes, on the first regular pay date following the date of your separation. 

(c) No Other Payments. Upon payment of the amounts to be paid pursuant to Sections 4.2(a) and 4.2(b) and such obligations as may be
required by applicable law, the Company shall have no further liability under this Offer Letter or as a result of your separation. 
 4.3
Release Required. You will not be entitled to receive the payment set forth in Section 4.2(a) and, if applicable, Section 8, unless you execute, at least seven days before the date payment is due to be made, and do
not revoke, a release in the form of Exhibit B in favor of the Company, Cott and related parties of all claims or liabilities of any kind relating to your employment with the Company and the termination of such employment (the
“Release”). 
 5. Other Termination. If your employment is terminated by (a) your voluntary resignation without
Good Reason, (b) your death, or (c) by the Company for Cause or as a result of your Disability, then you shall not be entitled to receive any other payments, entitlements or benefits other than Annual Base Salary earned through the date of
termination and reimbursement for expenses through the date of termination and, in either case, not yet paid. For greater certainty, with respect to a termination by reason of death or by reason of a Disability, nothing in this Offer Letter shall
derogate from any rights and/or entitlements that you may be entitled to receive under any other equity compensation or benefit plan of the Company applicable to you. 

6. Resignation. Upon your separation, you will be deemed to have resigned all positions you hold with the Company and any if its
Affiliates as of the date of your separation, including any director or officer positions, and you agree that upon termination you will execute such tenders of resignation as may be requested by the Company to evidence such resignations. 

7. Restrictive Covenants. 
 7.1
Confidentiality. 
 (a) You acknowledge that in the course of carrying out, performing and fulfilling your obligations to the
Company hereunder, you will have access to and be entrusted with information that would reasonably be considered confidential to the Company, Cott and other Cott Affiliates, the disclosure of which to competitors of the Company, Cott or other Cott
Affiliates or to the general public, would be highly detrimental to the best interests of the Company, Cott and/or other Cott Affiliates. Such information includes, without limitation, trade secrets, know-how,
marketing plans and techniques, cost figures, client lists, software, and information relating to employees, suppliers, customers and persons in contractual relationship with the Company, Cott or other Cott Affiliates. Except as may be required in
the course of carrying out your duties hereunder, you covenant and agree that you will not disclose, for the duration of your employment or at any time thereafter, any such information to any person, other than to the directors, officers, employees
or agents of the Company, Cott and Cott’s other Affiliates who 

  
 -3- 

 
have a need to know such information, nor shall you use or exploit, directly or indirectly, such information for any purpose other than for the purposes of the Company, Cott and Cott’s other
Affiliates, nor will you disclose or use for any purpose, other than for those of the Company, Cott or Cott’s other Affiliates, any other information which you may acquire during your employment with respect to the business and affairs of the
Company, Cott or Cott’s other Affiliates. Notwithstanding all of the foregoing, you shall be entitled to disclose such information if required pursuant to a subpoena or order issued by a court, arbitrator or governmental body, agency or
official, provided that you shall first have: 
 (i) notified the Company; 

(ii) consulted with the Company on whether there is an obligation or defense to providing some or all of the requested information; and 

(iii) if the disclosure is required or deemed advisable, cooperate with the Company in an attempt to obtain an order or other assurance that
such information will be accorded confidential treatment. 
 (b) Notwithstanding the foregoing, you may disclose information relating to
your own compensation and benefits to your spouse, attorneys, financial advisors and taxing authorities. Please note that pursuant to rules promulgated by the U.S. Securities and Exchange Commission under the Securities Exchange Act of 1934 in
effect on the date hereof, the amount and components of your compensation may be required to be publicly disclosed on an annual basis. 

7.2 Inventions. You acknowledge and agree that all right, title and interest in and to any information, trade
secrets, advances, discoveries, improvements, research materials and databases made or conceived by you prior to or during your employment relating to the business or affairs of the Company or Cott shall belong to the Company. In connection
with the foregoing, you agree to execute any assignments and/or acknowledgements as may be requested by the Company’s Chief Executive Officer from time to time. 

7.3 Corporate Opportunities. Any business opportunities related to the business of the Company or Cott which
become known to you during your employment with the Company must be fully disclosed and made available to the Company by you, and you agree not to take or attempt to take any action if the result would be to divert from the Company any opportunity
which is within the scope of its or Cott’s business. 
 7.4 Non-Competition and Non-Solicitation. 
 (a) You will not at any time, without the prior written consent of the
Company, during your employment with the Company and, if applicable, its Affiliates and for a period of twelve (12) months after your separation from such employment (regardless of the reason for such separation and whether caused by you or the
Company or one of its Affiliates), either individually or in partnership, jointly or in conjunction with any person or persons, firm, association, syndicate, corporation or company, whether as agent, shareholder, employee, consultant, or in any
manner whatsoever, directly or indirectly: 
 (i) anywhere in the Territory, engage in, work for, provide services to, carry on or
otherwise have any interest in, advise, lend money to, guarantee the debts or obligations of, permit your name to be used in connection with any business which is competitive to the Business or which provides the same or substantially similar
services as the Business; 

  
 -4- 

 (ii) for the purpose, or with the effect, of competing with any business of the Company, Cott or
any other Cott Affiliate, solicit, interfere with, accept any business from or render any services to anyone who is a client or a prospective client of the Company, Cott or any other Cott Affiliate at the time you ceased to be employed by the
Company or who was a client during the 12 months immediately preceding such time; or 
 (iii) solicit or offer employment to any
person employed or engaged by the Company, Cott or any other Cott Affiliate at the time you ceased to be employed by the Company or who was an employee during the 12-month period immediately preceding such
time. 
 (b) Nothing in this Offer Letter shall prohibit or restrict you from holding or becoming beneficially interested in up to one (1%)
percent of any class of securities in any company provided that such class of securities are listed on a recognized stock exchange in Canada or the United States. 

(c) If you are at any time in violation of any provision of this Section 7.4, then each time limitation set forth in this
Section 7.4 shall be extended for a period of time equal to the period of time during which such violation or violations occur. If the Company or Cott seeks injunctive relief from any such violation, then the covenants set forth shall be
extended for a period of time equal to the pendency of the proceeding in which relief is sought, including all appeals therefrom. 
 7.5
Insider and Other Company Policies. You will comply with all applicable securities laws and the Company’s and Cott’s insider trading policy and insider reporting procedures in respect of any securities of the
Company or Cott that you may acquire, and you will comply with all other of the Company’s and Cott’s policies that may be applicable to you from time to time, including, without limitation, the Company’s and Cott’s policies on
pricing, procurement, accounting, financial reporting, delegations of authority and responsibility, and conduct. 
 7.6 Non-Disparagement. The Company and you agree that neither party will disparage the other in any manner and will in all respects avoid any negative criticism of the other and, in your case, of Cott.
The foregoing non-disparagement provision does not apply on occasions when you or the Company provide truthful information in good faith to any federal, state, or local agency investigating an alleged
violation of any employment-related or other law or otherwise gathering information pursuant to any official investigation, hearing, trial or proceeding. You and the Company shall also (i) be permitted to defend your/itself against any
statement made by the other party that is intended or reasonably likely to disparage the other’s reputation if you or the Company, as applicable, have a reasonable good faith belief that your or its statements in such defense are not false
statements, (ii) be permitted, while you are employed by the Company, to make any statement not otherwise false or misleading that you or the Company, as applicable, determine in good faith is reasonably necessary or appropriate to the
discharge of your or its duties and responsibilities, and (iii) provide truthful testimony in any legal proceeding. The foregoing provision also does not prevent the Company and Cott from making internal statements or statements to outside
attorneys, auditors, or other advisors, in each case for legitimate business reasons to individuals who the Company or Cott reasonably believes has a need to know the information contained in the statements. Lastly, this section shall not prevent
you, during your employment, from discussing terms and conditions of your employment for mutual aid and protection and engaging in such other speech as may be protected by applicable law. 

  
 -5- 

 7.7 Injunctive Relief. 

(a) You acknowledge and agree that in the event of a breach of the covenants, provisions and restrictions in this Section 7, the
Company’s remedy in the form of monetary damages will be inadequate and that the Company, Cott and Cott’s other Affiliates shall be, and are hereby, authorized and entitled, in addition to all other rights and remedies available to them,
to apply for and obtain from a court of competent jurisdiction interim and permanent injunctive relief and an accounting of all profits and benefits arising out of such breach. 

(b) The parties acknowledge that the restrictions in this Section 7 are reasonable in all of the circumstances and you acknowledge that
the operation of restrictions contained in this Section 7 may seriously constrain your freedom to seek other remunerative employment. If any of the restrictions are determined to be unenforceable as going beyond what is reasonable in the
circumstances for the protection of the interests of the Company, Cott and Cott’s other Affiliates but would be valid, for example, if the scope of their time periods or geographic areas were limited, the parties consent to the court making
such modifications as may be required and such restrictions shall apply with such modifications as may be necessary to make them valid and effective. 

7.8 Survival of Restrictions. Each and every provision of this Section 7 shall survive the termination of
this Offer Letter or your employment (regardless of the reason for such termination). 
 7.9
Forfeiture/Recoupment. Notwithstanding the provisions of Section 4.2 or any other provision of this Offer Letter, if following the termination of your employment, you are entitled to payments or other benefits under
Section 4.2(a), but (i) the Company later determines that Cause with respect to your termination of employment existed at the time of your termination, (ii) you breach any provision of or revoke the Release, or (iii) you breach
any provision of Section 7 of this Offer Letter or any restrictive covenant contained in any other agreement between you and the Company or one of its Affiliates, then in each case you shall not be entitled to any payments or other benefits
pursuant to Section 4.2(a), any and all such payments to be made by the Company pursuant to Section 4.2(a) shall cease, and you shall return immediately any such other payments previously made to you. 

8. Code Section 409A. 

8.1 In General. This Section 8 shall apply to you if you are subject to Section 409A of the United
States Internal Revenue Code of 1986 (the “Code”), but only with respect to any payment due hereunder that is subject to Section 409A of the Code. 

8.2 Release. Any requirement that you execute and not revoke a release to receive a payment hereunder shall apply
to a payment described in Section 8.1 only if the Company provides the release to you on or before the date of your separation from employment. In no event shall the timing of your execution of the release, directly or indirectly, result
in your designating the calendar year of payment, and if a payment that is subject to execution of the release could be made in more than one taxable year, payment shall be made in the later taxable year. 

  
 -6- 

 8.3 Payment Following Separation. Notwithstanding any other provision
herein to the contrary, any payment described in Section 8.1 that is due to be paid within a stated period following your separation shall be paid: 

(a) If, at the time of your separation, you are a “specified employee” as defined in Section 409A of the Code, such payment
shall be made as of the later of (i) the date payment is due hereunder, or (ii) the earlier of the date which is six months after your “separation from service” (as defined under Section 409A of the Code), or the date of
your death; or 
 (b) In any other case, on the later of (i) last day of the stated period, or if such stated period is not more than
90 days, at any time during such stated period as determined by the Company without any input from you, or (ii) the date of your “separation from service” (as defined under Section 409A of the Code). 

8.4 Reimbursements. The following shall apply to any reimbursement that is a payment described in
Section 8.1: (a) with respect to any such reimbursement under Section 9.8, reimbursement shall not be made unless the expense is incurred during the period beginning on your effective hire date and ending on the sixth anniversary of your
death; (b) the amount of expenses eligible for reimbursement during your taxable year shall not affect the expenses eligible for reimbursement in any other year; and (c) the timing of all such reimbursements shall be as provided herein,
but not later than the last day of your taxable year following the taxable year in which the expense was incurred. 
 8.5
Offset. If you are subject to Section 409A of the Code, any offset under Section 9.11 shall apply to a payment described in Section 8.1 only if the debt or obligation was incurred in the ordinary course of your
employment with the Company, the entire amount of the set-off in any taxable year of the Company does not exceed $5,000, and the set-off is made at the same time and in
the same amount as the debt or obligation otherwise would have been due and collected from you. 
 8.6 Interpretation.
This Offer Letter shall be interpreted and construed so as to avoid the additional tax under Section 409A(a)(1)(B) of the Code to the maximum extent practicable. 

9. General Provisions. 
 9.1
Entire Agreement. This Offer Letter, together with the plans and documents referred to herein, constitutes and expresses the whole agreement of the parties hereto, or in the case of the Company any of its Affiliates or
direct or indirect subsidiaries, with reference to any of the matters or things herein provided for or herein before discussed or mentioned with reference to your employment and supersedes that offer letter dated August 11, 2016. All promises,
representation, collateral agreements and undertakings not expressly incorporated in this Offer Letter are hereby superseded by this Offer Letter; provided, however, that you reaffirm any post-separation obligations related to confidential or other
protectable information that you have to the Company or its Affiliates or subsidiaries (including as to the protection and non-use of such information), assign the right to enforce such obligations to the
Company, and acknowledge that going forward such obligations shall inure to the benefit of the Company, Cott and Cott’s other Affiliates. 

  
 -7- 

 9.2 Amendment. This Offer Letter may be amended or modified only by a
writing signed by both of the parties hereto. 
 9.3 Assignment. This Offer Letter may be assigned by the
Company to an Affiliate (including Cott) or any successor to its business or operations. Your rights hereunder may not be transferred by you except by will or by the laws of descent and distribution and except insofar as applicable law may otherwise
require. Any purported assignment in violation of the preceding sentence shall be void. 
 9.4 Governing Law; Consent to
Personal Jurisdiction and Venue. The validity, interpretation, and performance of this Offer Letter shall be governed, interpreted, and construed in accordance with the laws of the State of Florida without giving effect to the
principles of comity or conflicts of laws thereof. You hereby consent to personal jurisdiction and venue of the state and federal courts within the State of Florida, for any action brought by the Company and/or Cott arising out of a breach or
threatened breach of this Offer Letter or out of the relationship established by this Offer Letter and, unless and until such courts decline to exercise jurisdiction, you hereby agree that any action brought by you, alone or in combination with
others, against the Company or Cott, whether arising out of this Offer Letter or otherwise, shall be brought exclusively in the state and federal courts within the State of Florida. 

9.5 Severability. The invalidity of any one or more of the words, phrases, sentences, clauses or sections
contained in this Offer Letter shall not affect the enforceability of the remaining portions of the Offer Letter or any part thereof, all of which are inserted conditionally on their being valid in law, and, in the event that any one or more of the
words, phrases, sentences, clauses or sections contained in the Offer Letter shall be declared invalid, the Offer Letter shall be construed as if such invalid word or words, phrase or phrases, sentence or sentences, clause or clauses, or section or
sections had not been inserted. 
 9.6 Section Headings and Gender. The section headings contained herein are
for reference purposes only and shall not affect in any way the meaning or interpretation of this Offer Letter. All pronouns and any variations thereof shall be deemed to refer to the masculine, feminine or neuter, as the identity of the person or
persons may require. 
 9.7 No Term of Employment. Nothing herein obligates the Company to continue to employ
you. Where lawfully permitted in any jurisdiction in which you perform employment responsibilities on behalf of the Company, your employment shall be at will. 

9.8 Indemnification. 

(a) The Company will indemnify and hold you harmless to the maximum extent permitted by applicable law against judgments, fines, amounts paid
in settlement and reasonable expenses, including reasonable attorneys’ fees, in connection with the defense of, or as a result of any action or proceeding (or any appeal from any action or proceeding) in which you are made or are threatened to
be made a party by reason of the fact that you are or were an officer of the Company or any Affiliate. In addition, the Company agrees that you shall be covered and insured up to the maximum limits provided by any insurance which the Company
maintains to indemnify its directors and officers (as well as any insurance that it maintains to indemnify the Company for any obligations which it incurs as a result of its undertaking to indemnify its officers and directors). 

  
 -8- 

 (b) You shall not, however, be entitled to the advancement of expenses from the Company for any
claim that may arise under this Offer Letter and, further, in connection with any permitted advancement of expenses, you shall enter into a legally binding written agreement to reimburse the Company for any expenses advanced should it be ultimately
determined that you were not entitled to indemnification. 
 (c) Notwithstanding the above provisions of section 9.8, you shall not be
entitled to any indemnification or advancement of expenses in the event that the Company itself brings an action against you, including but not limited to actions for a breach of the fiduciary duty of loyalty or other torts. 

9.9 Survivorship. Upon the termination of your employment, the respective rights and obligations of the parties
shall survive such termination to the extent necessary to carry out the intended preservation of such rights and obligations. 
 9.10
Taxes. All payments under this Offer Letter shall be subject to withholding of such amounts, if any, relating to tax or other payroll deductions as the Company may reasonably determine and should withhold pursuant to any
applicable law or regulation. 
 9.11 Set-Off. Except as limited by
Section 8.5, the Company may set off any amount or obligation which may be owing by you to the Company or any Affiliate against any amount or obligation owing by the Company to you. 

9.12 Records. All books, records, and accounts relating in any manner to the Company, any Affiliate, or to any
suppliers, customers, or clients of the Company or any Affiliate, whether prepared by you or otherwise coming into your possession, shall be the exclusive property of the Company or its Affiliates, as applicable, and immediately returned to the
Company upon termination of employment or upon request at any time. 
 9.13 Counterparts. This Offer Letter may
be executed in counterparts, each of which shall be deemed to be an original but all of which together shall constitute one and the same instrument. 

9.14 Consultation with Counsel. You acknowledge that you have conferred with your own counsel with respect to this
Offer Letter, and that you understand the restrictions and limitations that it imposes upon your conduct. 
 — Remainder of Page Left
Blank Intentionally — 

  
 -9- 

 Ron, please indicate your acceptance of this offer by returning one signed original of this Offer Letter. 

Yours truly, 

/s/ Jerry Fowden 

Jerry Fowden 

Chief Executive Officer 
 I
accept this offer of employment and agree to be bound by the terms and conditions listed herein. 
  

							
				
	/s/ C. Ron Hinson	 		 		 	November 6, 2017
	C. Ron Hinson	 		 		 	Date

  

  
 -10- 

 Exhibit 10.1 

Exhibit A 

Definitions 

“Affiliate” shall mean, with respect to any person or entity (herein the “first party”), any other person or entity that
directs or indirectly controls, or is controlled by, or is under common control with, such first party. The term “control” as used herein (including the terms “controlled by” and “under common control with”) means the
possession, directly or indirectly, of the power to: (i) vote 50% or more of the outstanding voting securities of such person or entity, or (ii) otherwise direct or significantly influence the management or policies of such person or
entity by contract or otherwise. 
 “Business” means (i) the business of providing Company Products to the institutional food service
market, the convenience store market, the home and office coffee service delivery market, the commercial vending business and/or distributors who distribute the Company’s Products to end-user customers as
well as the servicing of machines that store and/or distribute Company Products, and (ii) any other business in which the Company or any other member of the Non-Compete Company Group is engaged at any
time during the Employment Term. 
 “Cause” shall mean your: 

(a) willful failure to properly carry out your duties and responsibilities or to adhere to the policies of the Company and, if applicable, its
Affiliates (including Cott) after written notice by the Company of the failure to do so, and such failure remaining uncorrected following an opportunity for you to correct the failure within ten (10) days of the receipt of such notice; 

(b) theft, fraud, embezzlement, self dealing, dishonesty or misappropriation, or the gross negligence or willful misconduct, involving the
property, business or affairs of the Company or its Affiliates (including Cott), or in the carrying out of your duties, including, without limitation, any material breach of the representations, warranties and covenants contained in any written
agreement with the Company, Cott or its Affiliates; 
 (c) conviction of or plea of guilty, plea of nolo contendore or no contest for any
felony or any criminal offence that involves fraud, dishonesty, theft, violence or moral turpitude; 
 (d) breach of a fiduciary duty owed
to the Company or any of its Affiliates (including Cott); 
 (e) refusal to follow the lawful written reasonable and good faith direction of
the Company’s Board of Directors or the Company’s or Cott’s Chief Executive Officer; provided such written directions are consistent with your position as the Chief Executive Officer of the Company; 

(f) intentional misconduct in connection with working for the Company, or intentional misconduct outside of work that harms or is likely to
harm the Company or its reputation; 
 (g) misrepresentation of your educational or professional experience; or 

(h) any act that causes the Company to violate any applicable laws or regulations 

 

 “Company Products” means coffee, tea, carbonated and
non-carbonated fountain and other beverages, beverage mixes, syrups and extracts, and specialty allied products. 

“Disability” shall mean any incapacity or inability by you, including any physical or mental incapacity, disease, illness or affliction,
which has prevented or which will likely prevent you from performing the essential duties of your position, with or without reasonable accommodation, for six (6) consecutive months or for any cumulative period of one hundred and twenty-five
(125) business days (whether or not consecutive) in any one (1) -year period, subject to applicable law. 
 “Good Reason” shall mean
any of the following: 
 (a) a material diminution in your title, authority, duties and responsibilities; unless such diminution is effected
with your approval; 
 (b) a reduction in your then-current Annual Base Salary or target bonus opportunity as a percentage of Annual Base
Salary, unless such reduction is made applicable to all Company senior executives; 
 (c) relocation of your principal place of employment
to a location that is more than seventy five (75) miles away from your principal place of employment on the Employment Date, unless such relocation is effected with your approval; or 

(d) a material breach by the Company of any provisions of this Offer Letter. 

You shall provide the Company with a written notice detailing the specific circumstances alleged to constitute Good Reason within ninety
(90) days after the first occurrence of such circumstances, provided, that no termination for Good Reason based on such circumstances shall occur more than one hundred eighty (180) days after the initial existence of such Good
Reason event. Upon receiving such notice, the Company shall have 30 days to cure the specific circumstances alleged to constitute Good Reason. Your failure to (i) provide the Company with written notice detailing the specific circumstances
alleged to constitute Good Reason within ninety (90) days after the first occurrence of such circumstances, or (ii) terminate for Good Reason within one hundred eighty (180) days from the first occurrence of such event, shall in
either case be deemed your irrevocable waiver of any claim that such circumstances may constitute “Good Reason,” but shall not prevent you from terminating for Good Reason in accordance with the terms of this Offer Letter based on
different or new circumstances constituting Good Reason. 
 “Non-Compete Company Group” will be
defined as the Company, Cott, and any of their subsidiaries, joint venturers or “sister” entities (but only those “sister” companies under common control by the same parent and which engage in the same businesses as the Company
or Cott). 
 “Territory” shall mean (i) anywhere the Company, Cott or its Affiliates manufactures, develops, markets or sells its
products at any time during the last 12 months of the Employment Term; and (ii) the continental United States. 
  

  
 -2- 

 Exhibit 10.1 

Exhibit B 

Form of Release 

RELEASE AGREEMENT 
 In consideration of
the mutual promises, payments and benefits provided for in the Offer Letter between S. & D. Coffee, Inc. (the “Company”) and Ron Hinson (the “Employee”) dated [______] the Company and the Employee agree to
the terms of this Release Agreement. Capitalized terms used and not defined in this Release Agreement shall have the meanings assigned thereto in the Offer Letter. 
  

	 	1	The Employee acknowledges and agrees that the Company is under no obligation to offer the Employee the payments and benefits set forth in Section 4.2(a) of the Offer Letter unless the Employee consents to the terms
of this Release Agreement. The Employee further acknowledges that he/she is under no obligation to consent to the terms of this Release Agreement and that the Employee has entered into this agreement freely and voluntarily. 

 

	 	2	In consideration of the payment and benefits set forth in the Offer Letter , the Employee voluntarily, knowingly and willingly releases and forever discharges the Company and its Affiliates (including but not limited to
the Cott Corporation), together with its and their respective officers, directors, partners, shareholders, employees and agents, and each of its and their predecessors, successors and assigns (collectively, “Releasees”), from any
and all charges, complaints, claims, promises, agreements, controversies, causes of action and demands of any nature whatsoever that the Employee or his/her executors, administrators, successors or assigns ever had, now have or hereafter can, shall
or may have against the Releasees by reason of any matter, cause or thing whatsoever arising prior to the time of signing of this Release Agreement by the Employee. The release being provided by the Employee in this Release Agreement includes, but
is not limited to, any rights or claims relating in any way to the Employee’s employment relationship with the Company or any its Affiliates, or the termination thereof, or under any statute, including, but not limited to the Employment
Standards Act, 2000, the Human Rights Code, the Workplace Safety and Insurance Act re-employment provisions, the Occupational Health &Safety Act, the Pay
Equity Act, the Labor Relations Act, Title VII of the Civil Rights Act of 1964, the Age Discrimination in Employment Act, as amended by the Older Workers’ Benefit Protection Act, the Family and Medical Leave
Act, and the Americans With Disabilities Act, or pursuant to any other applicable law or legislation governing or related to his/her employment or other engagement with the Company. The Employee is aware of his rights under the Human
Rights Code and represents, warrants, and hereby confirms that he is not asserting such rights, alleging that any such rights have been breached, or advancing a human rights claim or complaint. In no event shall this Release apply to the
Employee’s right, if any, to indemnification, under the Employee’s Offer Letter or otherwise, that is in effect on the date of this Release Agreement and, if applicable, to the Company’s obligation to maintain in force reasonable
director and officer insurance in respect of such indemnification obligations. 

  

	 	3	The Employee acknowledges and agrees that he/she shall not, directly or indirectly, seek or further be entitled to any personal recovery in any lawsuit or other claim against the Company or any other Releasee based on
any event arising out of the matters released in paragraph 2. 

  

	 	4	Nothing herein shall be deemed to release: (i) any of the Employee’s continuing rights under paragraph 4.2 of the Offer Letter; or (ii) any of the vested benefits that the Employee has accrued prior to
the date this Release Agreement is executed by the Employee under the employee benefit plans and arrangements of the Company or any of its Affiliates; or (iii) any claims that may arise after the date this Release Agreement is executed.

  

	 	5	Other than the payments set forth in Section 4.2(a) and, if applicable, Section 8 of the Offer Letter, the Employee acknowledges and agrees that he is not entitled to any further benefits from the company, and
has been paid any and all salary, bonuses, expense reimbursements or other amounts due from the Company. 

  

	 	6	The Employee acknowledges that he has carefully read and fully understands all of the provisions and effects of the Offer Letter and this Release Agreement. The Employee also acknowledges that the Company, by this
paragraph 6 and elsewhere, has advised him/her to consult with an attorney of his/her choice prior to signing this Release Agreement. The Employee represents that, to the extent he/she desires, he/she has had the opportunity to review this Release
Agreement with an attorney of his/her choice. 

  

	 	7	The Employee acknowledges that he/she has been offered the opportunity to consider the terms of this Release Agreement for a period of at least [twenty-one (21)/forty-five (45)]
days, although he/she may sign it sooner should he/she desire. The Employee further shall have seven (7) additional days from the date of signing this Release Agreement to revoke his/her consent hereto by notifying, in writing, the General
Counsel of the Cott Corporation. This Release Agreement will not become effective until seven days after the date on which the Employee has signed it without revocation. 

 

					
			
	Dated:	 		 	 

  

	
	S. & D. Coffee, Inc.
	
	   

	Name:
	Title:

  
 -2-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00276-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00276-of-00352.parquet"}]]